Based on the forecasted data for 2024 to 2028, deaths from trachea, bronchus, or lung malignant neoplasms in Canada are expected to exhibit a steady increase from 20.24 to 20.52 (in thousands). From 2023 to 2024, the forecast reflects an incremental rise, continuing this pattern into the subsequent years. The year-on-year percentage variation remains consistent over this period, indicating a gradual upward trend. The compound annual growth rate (CAGR) over the five-year forecast is expected to indicate a stable, albeit modest, increase in mortality rates.
As part of future trends, factors such as advancements in medical treatments, changes in smoking habits, early detection technologies, and public health initiatives could significantly drive changes in forecast outcomes. Monitoring these elements is crucial for accurate future projections and effective policy planning.
